The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Generic Health Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
303 result(s) found, displaying 51 to 60
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO GH 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO GH 250/100 atovaquone/proguanil hydrochloride 250/100 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO GH 250/100 atovaquone/proguanil hydrochloride 250/100 mg film-coated tablet blister pack.
-
ICATIBANT LUPIN icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe (364111)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ICATIBANT LUPIN icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ICATIBANT GH icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe.
-
Prescription medicine decision summaryTGA decision: Teriparatide Lupin and LAPL and GH (teriparatide acetate) are approved for the treatment of osteoporosis.
-
Cancellation or suspensionRegulatory action due to the product appearing to the Secretary that the quality, safety or efficacy of the goods was unacceptable, effective 29/03/2023
-
Prescription medicine registrationActive ingredients: Teriparatide.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CLOPIDOGREL LUPIN, clopidogrel (as hydrogen sulfate) 75 mg, film coated tablets, blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SILDENAFIL GH sildenafil (as citrate) 100 mg tablet blister pack.